nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—prostate cancer—Hydrocortisone—ulcerative colitis	0.223	0.388	CpDpCtD
Metoclopramide—CYP11B2—Hydrocortisone—ulcerative colitis	0.148	0.447	CbGbCtD
Metoclopramide—prostate cancer—Betamethasone—ulcerative colitis	0.136	0.237	CpDpCtD
Metoclopramide—prostate cancer—Dexamethasone—ulcerative colitis	0.136	0.237	CpDpCtD
Metoclopramide—CYP11B1—Hydrocortisone—ulcerative colitis	0.0961	0.29	CbGbCtD
Metoclopramide—migraine—Prednisone—ulcerative colitis	0.079	0.138	CpDpCtD
Metoclopramide—CYP17A1—Dexamethasone—ulcerative colitis	0.0598	0.18	CbGbCtD
Metoclopramide—HTR3A—enteric nervous system—ulcerative colitis	0.0122	0.524	CbGeAlD
Metoclopramide—CYP2D6—Nicotine—ulcerative colitis	0.012	0.0361	CbGbCtD
Metoclopramide—CYP2D6—Cholecalciferol—ulcerative colitis	0.0107	0.0324	CbGbCtD
Metoclopramide—HTR3A—myenteric nerve plexus—ulcerative colitis	0.00927	0.397	CbGeAlD
Metoclopramide—CYP2D6—Dexamethasone—ulcerative colitis	0.00464	0.014	CbGbCtD
Metoclopramide—Cinchocaine—CALM3—ulcerative colitis	0.00157	0.493	CrCbGaD
Metoclopramide—Sunitinib—JAK2—ulcerative colitis	0.000727	0.227	CrCbGaD
Metoclopramide—HTR3A—digestive system—ulcerative colitis	0.000702	0.0301	CbGeAlD
Metoclopramide—CYP17A1—liver—ulcerative colitis	0.000666	0.0286	CbGeAlD
Metoclopramide—Procainamide—SLC22A4—ulcerative colitis	0.000457	0.143	CrCbGaD
Metoclopramide—Procainamide—SLC22A5—ulcerative colitis	0.000344	0.108	CrCbGaD
Metoclopramide—CYP2D6—digestive system—ulcerative colitis	0.000258	0.0111	CbGeAlD
Metoclopramide—Visual disturbance—Prednisolone—ulcerative colitis	0.0002	0.00376	CcSEcCtD
Metoclopramide—Fatigue—Nicotine—ulcerative colitis	0.000197	0.00371	CcSEcCtD
Metoclopramide—Jaundice—Mesalazine—ulcerative colitis	0.000195	0.00368	CcSEcCtD
Metoclopramide—CYP2D6—liver—ulcerative colitis	0.000192	0.00824	CbGeAlD
Metoclopramide—Cardiac failure congestive—Triamcinolone—ulcerative colitis	0.000192	0.00362	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Methylprednisolone—ulcerative colitis	0.000192	0.00361	CcSEcCtD
Metoclopramide—Feeling abnormal—Nicotine—ulcerative colitis	0.000188	0.00354	CcSEcCtD
Metoclopramide—Nervousness—Budesonide—ulcerative colitis	0.000187	0.00352	CcSEcCtD
Metoclopramide—Agranulocytosis—Mesalazine—ulcerative colitis	0.000187	0.00352	CcSEcCtD
Metoclopramide—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000186	0.00351	CcSEcCtD
Metoclopramide—Muscle spasms—Budesonide—ulcerative colitis	0.000185	0.00349	CcSEcCtD
Metoclopramide—Urticaria—Nicotine—ulcerative colitis	0.000181	0.00342	CcSEcCtD
Metoclopramide—Tremor—Budesonide—ulcerative colitis	0.000181	0.0034	CcSEcCtD
Metoclopramide—Body temperature increased—Nicotine—ulcerative colitis	0.00018	0.0034	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisolone—ulcerative colitis	0.00018	0.00339	CcSEcCtD
Metoclopramide—Fluid retention—Prednisone—ulcerative colitis	0.00018	0.00339	CcSEcCtD
Metoclopramide—Agitation—Budesonide—ulcerative colitis	0.000177	0.00333	CcSEcCtD
Metoclopramide—Angioedema—Budesonide—ulcerative colitis	0.000176	0.00332	CcSEcCtD
Metoclopramide—Cardiac arrest—Hydrocortisone—ulcerative colitis	0.000176	0.00331	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Betamethasone—ulcerative colitis	0.000174	0.00328	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Dexamethasone—ulcerative colitis	0.000174	0.00328	CcSEcCtD
Metoclopramide—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000174	0.00327	CcSEcCtD
Metoclopramide—Palpitations—Budesonide—ulcerative colitis	0.00017	0.00321	CcSEcCtD
Metoclopramide—Hypersensitivity—Nicotine—ulcerative colitis	0.000168	0.00317	CcSEcCtD
Metoclopramide—Visual disturbance—Dexamethasone—ulcerative colitis	0.000167	0.00314	CcSEcCtD
Metoclopramide—Visual disturbance—Betamethasone—ulcerative colitis	0.000167	0.00314	CcSEcCtD
Metoclopramide—Hypertension—Budesonide—ulcerative colitis	0.000166	0.00313	CcSEcCtD
Metoclopramide—Cardiac arrest—Triamcinolone—ulcerative colitis	0.000166	0.00312	CcSEcCtD
Metoclopramide—Cardiac arrest—Methylprednisolone—ulcerative colitis	0.000165	0.00311	CcSEcCtD
Metoclopramide—Asthenia—Nicotine—ulcerative colitis	0.000164	0.00309	CcSEcCtD
Metoclopramide—Anxiety—Budesonide—ulcerative colitis	0.000163	0.00308	CcSEcCtD
Metoclopramide—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000161	0.00304	CcSEcCtD
Metoclopramide—Confusional state—Budesonide—ulcerative colitis	0.000159	0.00299	CcSEcCtD
Metoclopramide—Diarrhoea—Nicotine—ulcerative colitis	0.000156	0.00294	CcSEcCtD
Metoclopramide—Leukopenia—Azathioprine—ulcerative colitis	0.000154	0.0029	CcSEcCtD
Metoclopramide—Tachycardia—Budesonide—ulcerative colitis	0.000153	0.00289	CcSEcCtD
Metoclopramide—Nervousness—Mesalazine—ulcerative colitis	0.000152	0.00287	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisone—ulcerative colitis	0.000152	0.00286	CcSEcCtD
Metoclopramide—Dizziness—Nicotine—ulcerative colitis	0.000151	0.00284	CcSEcCtD
Metoclopramide—Muscle spasms—Mesalazine—ulcerative colitis	0.000151	0.00284	CcSEcCtD
Metoclopramide—Asthma—Triamcinolone—ulcerative colitis	0.000151	0.00284	CcSEcCtD
Metoclopramide—Cardiac arrest—Betamethasone—ulcerative colitis	0.00015	0.00283	CcSEcCtD
Metoclopramide—Cardiac arrest—Dexamethasone—ulcerative colitis	0.00015	0.00283	CcSEcCtD
Metoclopramide—Rash—Mercaptopurine—ulcerative colitis	0.000149	0.0028	CcSEcCtD
Metoclopramide—Dermatitis—Mercaptopurine—ulcerative colitis	0.000148	0.0028	CcSEcCtD
Metoclopramide—Bronchospasm—Methylprednisolone—ulcerative colitis	0.000148	0.00278	CcSEcCtD
Metoclopramide—Tremor—Mesalazine—ulcerative colitis	0.000147	0.00276	CcSEcCtD
Metoclopramide—Rash—Nicotine—ulcerative colitis	0.000144	0.00271	CcSEcCtD
Metoclopramide—Dermatitis—Nicotine—ulcerative colitis	0.000144	0.00271	CcSEcCtD
Metoclopramide—Angioedema—Mesalazine—ulcerative colitis	0.000143	0.0027	CcSEcCtD
Metoclopramide—Headache—Nicotine—ulcerative colitis	0.000143	0.00269	CcSEcCtD
Metoclopramide—Insomnia—Budesonide—ulcerative colitis	0.000142	0.00268	CcSEcCtD
Metoclopramide—Leukopenia—Mesalazine—ulcerative colitis	0.00014	0.00264	CcSEcCtD
Metoclopramide—Dyspnoea—Budesonide—ulcerative colitis	0.00014	0.00264	CcSEcCtD
Metoclopramide—Nausea—Mercaptopurine—ulcerative colitis	0.00014	0.00264	CcSEcCtD
Metoclopramide—Somnolence—Budesonide—ulcerative colitis	0.00014	0.00263	CcSEcCtD
Metoclopramide—Palpitations—Mesalazine—ulcerative colitis	0.000138	0.00261	CcSEcCtD
Metoclopramide—Nausea—Nicotine—ulcerative colitis	0.000136	0.00255	CcSEcCtD
Metoclopramide—Fatigue—Budesonide—ulcerative colitis	0.000136	0.00255	CcSEcCtD
Metoclopramide—Hypertension—Mesalazine—ulcerative colitis	0.000135	0.00255	CcSEcCtD
Metoclopramide—Bradycardia—Prednisolone—ulcerative colitis	0.000133	0.00251	CcSEcCtD
Metoclopramide—Anxiety—Mesalazine—ulcerative colitis	0.000133	0.0025	CcSEcCtD
Metoclopramide—Hypotension—Azathioprine—ulcerative colitis	0.000131	0.00247	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—ulcerative colitis	0.000131	0.00247	CcSEcCtD
Metoclopramide—Bradycardia—Hydrocortisone—ulcerative colitis	0.00013	0.00245	CcSEcCtD
Metoclopramide—Feeling abnormal—Budesonide—ulcerative colitis	0.00013	0.00244	CcSEcCtD
Metoclopramide—Confusional state—Mesalazine—ulcerative colitis	0.000129	0.00243	CcSEcCtD
Metoclopramide—Oedema—Mesalazine—ulcerative colitis	0.000128	0.00241	CcSEcCtD
Metoclopramide—Hallucination—Hydrocortisone—ulcerative colitis	0.000127	0.0024	CcSEcCtD
Metoclopramide—Visual impairment—Prednisolone—ulcerative colitis	0.000126	0.00238	CcSEcCtD
Metoclopramide—Urticaria—Budesonide—ulcerative colitis	0.000125	0.00235	CcSEcCtD
Metoclopramide—Tachycardia—Mesalazine—ulcerative colitis	0.000125	0.00235	CcSEcCtD
Metoclopramide—Body temperature increased—Budesonide—ulcerative colitis	0.000124	0.00234	CcSEcCtD
Metoclopramide—Bradycardia—Triamcinolone—ulcerative colitis	0.000123	0.00231	CcSEcCtD
Metoclopramide—Bradycardia—Methylprednisolone—ulcerative colitis	0.000122	0.00231	CcSEcCtD
Metoclopramide—Hallucination—Methylprednisolone—ulcerative colitis	0.00012	0.00225	CcSEcCtD
Metoclopramide—Hypotension—Mesalazine—ulcerative colitis	0.000119	0.00225	CcSEcCtD
Metoclopramide—Visual impairment—Methylprednisolone—ulcerative colitis	0.000116	0.00218	CcSEcCtD
Metoclopramide—Hypersensitivity—Budesonide—ulcerative colitis	0.000116	0.00218	CcSEcCtD
Metoclopramide—Feeling abnormal—Azathioprine—ulcerative colitis	0.000116	0.00218	CcSEcCtD
Metoclopramide—Insomnia—Mesalazine—ulcerative colitis	0.000116	0.00218	CcSEcCtD
Metoclopramide—Dyspnoea—Mesalazine—ulcerative colitis	0.000114	0.00215	CcSEcCtD
Metoclopramide—Somnolence—Mesalazine—ulcerative colitis	0.000114	0.00214	CcSEcCtD
Metoclopramide—Asthenia—Budesonide—ulcerative colitis	0.000113	0.00212	CcSEcCtD
Metoclopramide—Bradycardia—Betamethasone—ulcerative colitis	0.000111	0.0021	CcSEcCtD
Metoclopramide—Bradycardia—Dexamethasone—ulcerative colitis	0.000111	0.0021	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—ulcerative colitis	0.000111	0.0021	CcSEcCtD
Metoclopramide—Body temperature increased—Azathioprine—ulcerative colitis	0.000111	0.00209	CcSEcCtD
Metoclopramide—Fatigue—Mesalazine—ulcerative colitis	0.00011	0.00208	CcSEcCtD
Metoclopramide—Erectile dysfunction—Prednisone—ulcerative colitis	0.00011	0.00206	CcSEcCtD
Metoclopramide—Hallucination—Betamethasone—ulcerative colitis	0.000109	0.00205	CcSEcCtD
Metoclopramide—Hallucination—Dexamethasone—ulcerative colitis	0.000109	0.00205	CcSEcCtD
Metoclopramide—Diarrhoea—Budesonide—ulcerative colitis	0.000108	0.00203	CcSEcCtD
Metoclopramide—Depression—Prednisone—ulcerative colitis	0.000106	0.00199	CcSEcCtD
Metoclopramide—Visual impairment—Dexamethasone—ulcerative colitis	0.000105	0.00198	CcSEcCtD
Metoclopramide—Visual impairment—Betamethasone—ulcerative colitis	0.000105	0.00198	CcSEcCtD
Metoclopramide—Feeling abnormal—Mesalazine—ulcerative colitis	0.000105	0.00198	CcSEcCtD
Metoclopramide—Angioedema—Prednisolone—ulcerative colitis	0.000104	0.00196	CcSEcCtD
Metoclopramide—Dizziness—Budesonide—ulcerative colitis	0.000104	0.00196	CcSEcCtD
Metoclopramide—Hypersensitivity—Azathioprine—ulcerative colitis	0.000103	0.00195	CcSEcCtD
Metoclopramide—Angioedema—Hydrocortisone—ulcerative colitis	0.000102	0.00192	CcSEcCtD
Metoclopramide—Urticaria—Mesalazine—ulcerative colitis	0.000102	0.00191	CcSEcCtD
Metoclopramide—Body temperature increased—Mesalazine—ulcerative colitis	0.000101	0.0019	CcSEcCtD
Metoclopramide—Rash—Budesonide—ulcerative colitis	9.91e-05	0.00187	CcSEcCtD
Metoclopramide—Dermatitis—Budesonide—ulcerative colitis	9.91e-05	0.00187	CcSEcCtD
Metoclopramide—Convulsion—Prednisolone—ulcerative colitis	9.89e-05	0.00186	CcSEcCtD
Metoclopramide—Headache—Budesonide—ulcerative colitis	9.85e-05	0.00186	CcSEcCtD
Metoclopramide—Hypertension—Prednisolone—ulcerative colitis	9.85e-05	0.00186	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—ulcerative colitis	9.7e-05	0.00183	CcSEcCtD
Metoclopramide—Convulsion—Hydrocortisone—ulcerative colitis	9.65e-05	0.00182	CcSEcCtD
Metoclopramide—Hypertension—Hydrocortisone—ulcerative colitis	9.62e-05	0.00181	CcSEcCtD
Metoclopramide—Diarrhoea—Azathioprine—ulcerative colitis	9.61e-05	0.00181	CcSEcCtD
Metoclopramide—Angioedema—Triamcinolone—ulcerative colitis	9.59e-05	0.00181	CcSEcCtD
Metoclopramide—Angioedema—Methylprednisolone—ulcerative colitis	9.57e-05	0.0018	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—ulcerative colitis	9.48e-05	0.00178	CcSEcCtD
Metoclopramide—Anxiety—Hydrocortisone—ulcerative colitis	9.45e-05	0.00178	CcSEcCtD
Metoclopramide—Hypersensitivity—Mesalazine—ulcerative colitis	9.42e-05	0.00177	CcSEcCtD
Metoclopramide—Nausea—Budesonide—ulcerative colitis	9.34e-05	0.00176	CcSEcCtD
Metoclopramide—Sunitinib—ABCB1—ulcerative colitis	9.32e-05	0.0292	CrCbGaD
Metoclopramide—Oedema—Prednisolone—ulcerative colitis	9.31e-05	0.00175	CcSEcCtD
Metoclopramide—Dizziness—Azathioprine—ulcerative colitis	9.28e-05	0.00175	CcSEcCtD
Metoclopramide—Asthenia—Mesalazine—ulcerative colitis	9.18e-05	0.00173	CcSEcCtD
Metoclopramide—Oedema—Hydrocortisone—ulcerative colitis	9.09e-05	0.00171	CcSEcCtD
Metoclopramide—Convulsion—Triamcinolone—ulcerative colitis	9.09e-05	0.00171	CcSEcCtD
Metoclopramide—Tachycardia—Prednisolone—ulcerative colitis	9.09e-05	0.00171	CcSEcCtD
Metoclopramide—Convulsion—Methylprednisolone—ulcerative colitis	9.07e-05	0.00171	CcSEcCtD
Metoclopramide—Hypertension—Triamcinolone—ulcerative colitis	9.06e-05	0.00171	CcSEcCtD
Metoclopramide—Hypertension—Methylprednisolone—ulcerative colitis	9.04e-05	0.0017	CcSEcCtD
Metoclopramide—Anxiety—Methylprednisolone—ulcerative colitis	8.88e-05	0.00167	CcSEcCtD
Metoclopramide—Tachycardia—Hydrocortisone—ulcerative colitis	8.88e-05	0.00167	CcSEcCtD
Metoclopramide—Rash—Azathioprine—ulcerative colitis	8.85e-05	0.00167	CcSEcCtD
Metoclopramide—Dermatitis—Azathioprine—ulcerative colitis	8.84e-05	0.00167	CcSEcCtD
Metoclopramide—Flushing—Prednisone—ulcerative colitis	8.84e-05	0.00166	CcSEcCtD
Metoclopramide—Headache—Azathioprine—ulcerative colitis	8.8e-05	0.00166	CcSEcCtD
Metoclopramide—Diarrhoea—Mesalazine—ulcerative colitis	8.75e-05	0.00165	CcSEcCtD
Metoclopramide—Angioedema—Betamethasone—ulcerative colitis	8.7e-05	0.00164	CcSEcCtD
Metoclopramide—Angioedema—Dexamethasone—ulcerative colitis	8.7e-05	0.00164	CcSEcCtD
Metoclopramide—Confusional state—Methylprednisolone—ulcerative colitis	8.61e-05	0.00162	CcSEcCtD
Metoclopramide—Oedema—Triamcinolone—ulcerative colitis	8.56e-05	0.00161	CcSEcCtD
Metoclopramide—Hypotension—Hydrocortisone—ulcerative colitis	8.5e-05	0.0016	CcSEcCtD
Metoclopramide—Dizziness—Mesalazine—ulcerative colitis	8.46e-05	0.00159	CcSEcCtD
Metoclopramide—Insomnia—Prednisolone—ulcerative colitis	8.42e-05	0.00159	CcSEcCtD
Metoclopramide—Tachycardia—Triamcinolone—ulcerative colitis	8.36e-05	0.00157	CcSEcCtD
Metoclopramide—Nausea—Azathioprine—ulcerative colitis	8.34e-05	0.00157	CcSEcCtD
Metoclopramide—Tachycardia—Methylprednisolone—ulcerative colitis	8.34e-05	0.00157	CcSEcCtD
Metoclopramide—Convulsion—Betamethasone—ulcerative colitis	8.25e-05	0.00155	CcSEcCtD
Metoclopramide—Convulsion—Dexamethasone—ulcerative colitis	8.25e-05	0.00155	CcSEcCtD
Metoclopramide—Insomnia—Hydrocortisone—ulcerative colitis	8.23e-05	0.00155	CcSEcCtD
Metoclopramide—Hypertension—Dexamethasone—ulcerative colitis	8.22e-05	0.00155	CcSEcCtD
Metoclopramide—Hypertension—Betamethasone—ulcerative colitis	8.22e-05	0.00155	CcSEcCtD
Metoclopramide—Anxiety—Betamethasone—ulcerative colitis	8.08e-05	0.00152	CcSEcCtD
Metoclopramide—Anxiety—Dexamethasone—ulcerative colitis	8.08e-05	0.00152	CcSEcCtD
Metoclopramide—Rash—Mesalazine—ulcerative colitis	8.06e-05	0.00152	CcSEcCtD
Metoclopramide—Dermatitis—Mesalazine—ulcerative colitis	8.06e-05	0.00152	CcSEcCtD
Metoclopramide—Headache—Mesalazine—ulcerative colitis	8.01e-05	0.00151	CcSEcCtD
Metoclopramide—Hypotension—Methylprednisolone—ulcerative colitis	7.98e-05	0.0015	CcSEcCtD
Metoclopramide—Fatigue—Hydrocortisone—ulcerative colitis	7.84e-05	0.00148	CcSEcCtD
Metoclopramide—Oedema—Betamethasone—ulcerative colitis	7.77e-05	0.00146	CcSEcCtD
Metoclopramide—Oedema—Dexamethasone—ulcerative colitis	7.77e-05	0.00146	CcSEcCtD
Metoclopramide—Insomnia—Triamcinolone—ulcerative colitis	7.74e-05	0.00146	CcSEcCtD
Metoclopramide—Insomnia—Methylprednisolone—ulcerative colitis	7.73e-05	0.00146	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisolone—ulcerative colitis	7.67e-05	0.00145	CcSEcCtD
Metoclopramide—Dyspnoea—Triamcinolone—ulcerative colitis	7.63e-05	0.00144	CcSEcCtD
Metoclopramide—Agitation—Prednisone—ulcerative colitis	7.62e-05	0.00143	CcSEcCtD
Metoclopramide—Nausea—Mesalazine—ulcerative colitis	7.6e-05	0.00143	CcSEcCtD
Metoclopramide—Tachycardia—Betamethasone—ulcerative colitis	7.58e-05	0.00143	CcSEcCtD
Metoclopramide—Tachycardia—Dexamethasone—ulcerative colitis	7.58e-05	0.00143	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—ulcerative colitis	7.58e-05	0.00143	CcSEcCtD
Metoclopramide—Feeling abnormal—Hydrocortisone—ulcerative colitis	7.49e-05	0.00141	CcSEcCtD
Metoclopramide—Urticaria—Prednisolone—ulcerative colitis	7.4e-05	0.00139	CcSEcCtD
Metoclopramide—Fatigue—Triamcinolone—ulcerative colitis	7.38e-05	0.00139	CcSEcCtD
Metoclopramide—Fatigue—Methylprednisolone—ulcerative colitis	7.37e-05	0.00139	CcSEcCtD
Metoclopramide—Hypotension—Betamethasone—ulcerative colitis	7.26e-05	0.00137	CcSEcCtD
Metoclopramide—Hypotension—Dexamethasone—ulcerative colitis	7.26e-05	0.00137	CcSEcCtD
Metoclopramide—Urticaria—Hydrocortisone—ulcerative colitis	7.22e-05	0.00136	CcSEcCtD
Metoclopramide—Body temperature increased—Hydrocortisone—ulcerative colitis	7.19e-05	0.00135	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—ulcerative colitis	7.18e-05	0.00135	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—ulcerative colitis	7.16e-05	0.00135	CcSEcCtD
Metoclopramide—Feeling abnormal—Triamcinolone—ulcerative colitis	7.06e-05	0.00133	CcSEcCtD
Metoclopramide—Feeling abnormal—Methylprednisolone—ulcerative colitis	7.04e-05	0.00133	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—ulcerative colitis	7.03e-05	0.00132	CcSEcCtD
Metoclopramide—Insomnia—Betamethasone—ulcerative colitis	7.03e-05	0.00132	CcSEcCtD
Metoclopramide—Insomnia—Dexamethasone—ulcerative colitis	7.03e-05	0.00132	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisolone—ulcerative colitis	6.86e-05	0.00129	CcSEcCtD
Metoclopramide—Urticaria—Triamcinolone—ulcerative colitis	6.8e-05	0.00128	CcSEcCtD
Metoclopramide—Urticaria—Methylprednisolone—ulcerative colitis	6.79e-05	0.00128	CcSEcCtD
Metoclopramide—Body temperature increased—Triamcinolone—ulcerative colitis	6.77e-05	0.00127	CcSEcCtD
Metoclopramide—Oedema—Prednisone—ulcerative colitis	6.77e-05	0.00127	CcSEcCtD
Metoclopramide—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.7e-05	0.00126	CcSEcCtD
Metoclopramide—Fatigue—Dexamethasone—ulcerative colitis	6.7e-05	0.00126	CcSEcCtD
Metoclopramide—Fatigue—Betamethasone—ulcerative colitis	6.7e-05	0.00126	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—ulcerative colitis	6.6e-05	0.00124	CcSEcCtD
Metoclopramide—Asthenia—Hydrocortisone—ulcerative colitis	6.52e-05	0.00123	CcSEcCtD
Metoclopramide—Feeling abnormal—Dexamethasone—ulcerative colitis	6.4e-05	0.00121	CcSEcCtD
Metoclopramide—Feeling abnormal—Betamethasone—ulcerative colitis	6.4e-05	0.00121	CcSEcCtD
Metoclopramide—Hypersensitivity—Triamcinolone—ulcerative colitis	6.31e-05	0.00119	CcSEcCtD
Metoclopramide—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.29e-05	0.00119	CcSEcCtD
Metoclopramide—Diarrhoea—Hydrocortisone—ulcerative colitis	6.22e-05	0.00117	CcSEcCtD
Metoclopramide—Urticaria—Dexamethasone—ulcerative colitis	6.17e-05	0.00116	CcSEcCtD
Metoclopramide—Urticaria—Betamethasone—ulcerative colitis	6.17e-05	0.00116	CcSEcCtD
Metoclopramide—Dizziness—Prednisolone—ulcerative colitis	6.16e-05	0.00116	CcSEcCtD
Metoclopramide—Asthenia—Triamcinolone—ulcerative colitis	6.14e-05	0.00116	CcSEcCtD
Metoclopramide—Body temperature increased—Dexamethasone—ulcerative colitis	6.14e-05	0.00116	CcSEcCtD
Metoclopramide—Body temperature increased—Betamethasone—ulcerative colitis	6.14e-05	0.00116	CcSEcCtD
Metoclopramide—Asthenia—Methylprednisolone—ulcerative colitis	6.13e-05	0.00115	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—ulcerative colitis	6.12e-05	0.00115	CcSEcCtD
Metoclopramide—Dizziness—Hydrocortisone—ulcerative colitis	6.01e-05	0.00113	CcSEcCtD
Metoclopramide—Rash—Prednisolone—ulcerative colitis	5.87e-05	0.00111	CcSEcCtD
Metoclopramide—Dermatitis—Prednisolone—ulcerative colitis	5.87e-05	0.0011	CcSEcCtD
Metoclopramide—Diarrhoea—Methylprednisolone—ulcerative colitis	5.85e-05	0.0011	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—ulcerative colitis	5.83e-05	0.0011	CcSEcCtD
Metoclopramide—Headache—Prednisolone—ulcerative colitis	5.83e-05	0.0011	CcSEcCtD
Metoclopramide—Rash—Hydrocortisone—ulcerative colitis	5.73e-05	0.00108	CcSEcCtD
Metoclopramide—Dermatitis—Hydrocortisone—ulcerative colitis	5.73e-05	0.00108	CcSEcCtD
Metoclopramide—Headache—Hydrocortisone—ulcerative colitis	5.7e-05	0.00107	CcSEcCtD
Metoclopramide—Dizziness—Triamcinolone—ulcerative colitis	5.66e-05	0.00107	CcSEcCtD
Metoclopramide—Dizziness—Methylprednisolone—ulcerative colitis	5.65e-05	0.00106	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—ulcerative colitis	5.58e-05	0.00105	CcSEcCtD
Metoclopramide—Asthenia—Betamethasone—ulcerative colitis	5.57e-05	0.00105	CcSEcCtD
Metoclopramide—Asthenia—Dexamethasone—ulcerative colitis	5.57e-05	0.00105	CcSEcCtD
Metoclopramide—Nausea—Prednisolone—ulcerative colitis	5.53e-05	0.00104	CcSEcCtD
Metoclopramide—Nausea—Hydrocortisone—ulcerative colitis	5.4e-05	0.00102	CcSEcCtD
Metoclopramide—Rash—Triamcinolone—ulcerative colitis	5.4e-05	0.00102	CcSEcCtD
Metoclopramide—Dermatitis—Triamcinolone—ulcerative colitis	5.39e-05	0.00102	CcSEcCtD
Metoclopramide—Rash—Methylprednisolone—ulcerative colitis	5.39e-05	0.00101	CcSEcCtD
Metoclopramide—Dermatitis—Methylprednisolone—ulcerative colitis	5.38e-05	0.00101	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—ulcerative colitis	5.38e-05	0.00101	CcSEcCtD
Metoclopramide—Headache—Triamcinolone—ulcerative colitis	5.36e-05	0.00101	CcSEcCtD
Metoclopramide—Headache—Methylprednisolone—ulcerative colitis	5.35e-05	0.00101	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—ulcerative colitis	5.35e-05	0.00101	CcSEcCtD
Metoclopramide—Diarrhoea—Dexamethasone—ulcerative colitis	5.32e-05	0.001	CcSEcCtD
Metoclopramide—Diarrhoea—Betamethasone—ulcerative colitis	5.32e-05	0.001	CcSEcCtD
Metoclopramide—Dizziness—Dexamethasone—ulcerative colitis	5.14e-05	0.000968	CcSEcCtD
Metoclopramide—Dizziness—Betamethasone—ulcerative colitis	5.14e-05	0.000968	CcSEcCtD
Metoclopramide—Nausea—Triamcinolone—ulcerative colitis	5.09e-05	0.000958	CcSEcCtD
Metoclopramide—Nausea—Methylprednisolone—ulcerative colitis	5.07e-05	0.000956	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—ulcerative colitis	4.99e-05	0.000939	CcSEcCtD
Metoclopramide—Rash—Dexamethasone—ulcerative colitis	4.9e-05	0.000923	CcSEcCtD
Metoclopramide—Rash—Betamethasone—ulcerative colitis	4.9e-05	0.000923	CcSEcCtD
Metoclopramide—Dermatitis—Betamethasone—ulcerative colitis	4.89e-05	0.000922	CcSEcCtD
Metoclopramide—Dermatitis—Dexamethasone—ulcerative colitis	4.89e-05	0.000922	CcSEcCtD
Metoclopramide—Headache—Dexamethasone—ulcerative colitis	4.87e-05	0.000917	CcSEcCtD
Metoclopramide—Headache—Betamethasone—ulcerative colitis	4.87e-05	0.000917	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—ulcerative colitis	4.85e-05	0.000914	CcSEcCtD
Metoclopramide—Diarrhoea—Prednisone—ulcerative colitis	4.63e-05	0.000872	CcSEcCtD
Metoclopramide—Nausea—Betamethasone—ulcerative colitis	4.61e-05	0.000869	CcSEcCtD
Metoclopramide—Nausea—Dexamethasone—ulcerative colitis	4.61e-05	0.000869	CcSEcCtD
Metoclopramide—Dizziness—Prednisone—ulcerative colitis	4.47e-05	0.000843	CcSEcCtD
Metoclopramide—Rash—Prednisone—ulcerative colitis	4.27e-05	0.000803	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—ulcerative colitis	4.26e-05	0.000803	CcSEcCtD
Metoclopramide—Headache—Prednisone—ulcerative colitis	4.24e-05	0.000798	CcSEcCtD
Metoclopramide—Nausea—Prednisone—ulcerative colitis	4.02e-05	0.000757	CcSEcCtD
Metoclopramide—DRD2—GPCR ligand binding—CXCR2—ulcerative colitis	2.7e-05	0.00173	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	2.68e-05	0.00172	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—GHRL—ulcerative colitis	2.67e-05	0.00171	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCR2—ulcerative colitis	2.64e-05	0.00169	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—ADCY5—ulcerative colitis	2.64e-05	0.00169	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	2.63e-05	0.00168	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—PPARG—ulcerative colitis	2.62e-05	0.00168	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MAML2—ulcerative colitis	2.61e-05	0.00167	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	2.59e-05	0.00166	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCR1—ulcerative colitis	2.55e-05	0.00163	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	2.54e-05	0.00163	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCR6—ulcerative colitis	2.54e-05	0.00162	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCR6—ulcerative colitis	2.48e-05	0.00159	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PTGER4—ulcerative colitis	2.42e-05	0.00155	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—ADCY5—ulcerative colitis	2.37e-05	0.00152	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.33e-05	0.00149	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCR1—ulcerative colitis	2.31e-05	0.00148	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCL20—ulcerative colitis	2.24e-05	0.00143	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—PTGER4—ulcerative colitis	2.23e-05	0.00143	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	2.22e-05	0.00142	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—GHRL—ulcerative colitis	2.22e-05	0.00142	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—ADRB2—ulcerative colitis	2.21e-05	0.00142	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—PTGER4—ulcerative colitis	2.19e-05	0.0014	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	2.17e-05	0.00139	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CALM3—ulcerative colitis	2.15e-05	0.00138	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS1—ulcerative colitis	2.13e-05	0.00137	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RIPK2—ulcerative colitis	2.12e-05	0.00135	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—GNA12—ulcerative colitis	2.1e-05	0.00135	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.1e-05	0.00134	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—GHRL—ulcerative colitis	2.04e-05	0.00131	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL20—ulcerative colitis	2.03e-05	0.0013	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.01e-05	0.00129	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—PPARG—ulcerative colitis	2e-05	0.00128	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—GHRL—ulcerative colitis	2e-05	0.00128	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCR2—ulcerative colitis	1.99e-05	0.00128	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—PPARG—ulcerative colitis	1.96e-05	0.00126	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.95e-05	0.00125	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCR1—ulcerative colitis	1.95e-05	0.00125	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CALM3—ulcerative colitis	1.92e-05	0.00123	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—GNA12—ulcerative colitis	1.91e-05	0.00122	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	1.91e-05	0.00122	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.88e-05	0.0012	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCR6—ulcerative colitis	1.87e-05	0.0012	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS1—ulcerative colitis	1.84e-05	0.00118	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ADRB2—ulcerative colitis	1.84e-05	0.00118	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.84e-05	0.00118	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—JAK2—ulcerative colitis	1.81e-05	0.00116	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCR2—ulcerative colitis	1.81e-05	0.00116	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.81e-05	0.00116	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCR1—ulcerative colitis	1.77e-05	0.00113	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.76e-05	0.00113	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCR1—ulcerative colitis	1.73e-05	0.00111	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS1—ulcerative colitis	1.72e-05	0.0011	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCL20—ulcerative colitis	1.71e-05	0.0011	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR6—ulcerative colitis	1.7e-05	0.00109	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—ADRB2—ulcerative colitis	1.69e-05	0.00108	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.69e-05	0.00108	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCL20—ulcerative colitis	1.67e-05	0.00107	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SEL1L—ulcerative colitis	1.66e-05	0.00106	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—ADRB2—ulcerative colitis	1.66e-05	0.00106	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CALM3—ulcerative colitis	1.66e-05	0.00106	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CXCL8—ulcerative colitis	1.65e-05	0.00106	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PTGER4—ulcerative colitis	1.65e-05	0.00106	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—JAK2—ulcerative colitis	1.64e-05	0.00105	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—GNA12—ulcerative colitis	1.61e-05	0.00103	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.58e-05	0.00101	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—IL2—ulcerative colitis	1.58e-05	0.00101	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—GNA12—ulcerative colitis	1.57e-05	0.00101	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ADCY5—ulcerative colitis	1.56e-05	0.000998	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	1.55e-05	0.000995	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL20—ulcerative colitis	1.55e-05	0.000994	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CALM3—ulcerative colitis	1.55e-05	0.000991	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCR2—ulcerative colitis	1.52e-05	0.000976	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL20—ulcerative colitis	1.52e-05	0.000973	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—GHRL—ulcerative colitis	1.51e-05	0.000967	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CXCL8—ulcerative colitis	1.5e-05	0.000961	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PTGER4—ulcerative colitis	1.5e-05	0.000959	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ABCB1—ulcerative colitis	1.49e-05	0.000956	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	1.49e-05	0.000955	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.48e-05	0.000947	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—GNA12—ulcerative colitis	1.46e-05	0.000935	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL2—ulcerative colitis	1.43e-05	0.000918	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR6—ulcerative colitis	1.43e-05	0.000918	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—GNA12—ulcerative colitis	1.43e-05	0.000915	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR6—ulcerative colitis	1.4e-05	0.000898	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.4e-05	0.000898	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ADCY5—ulcerative colitis	1.39e-05	0.000892	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCR2—ulcerative colitis	1.38e-05	0.000886	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—GHRL—ulcerative colitis	1.37e-05	0.000878	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCR1—ulcerative colitis	1.37e-05	0.000874	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCR2—ulcerative colitis	1.35e-05	0.000867	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CXCL8—ulcerative colitis	1.35e-05	0.000864	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CALM3—ulcerative colitis	1.33e-05	0.00085	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR6—ulcerative colitis	1.3e-05	0.000833	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ABCB1—ulcerative colitis	1.29e-05	0.000824	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR6—ulcerative colitis	1.27e-05	0.000816	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SEL1L—ulcerative colitis	1.27e-05	0.000813	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PTGER4—ulcerative colitis	1.26e-05	0.000808	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADRB2—ulcerative colitis	1.25e-05	0.0008	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SEL1L—ulcerative colitis	1.24e-05	0.000795	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	1.23e-05	0.000791	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—TP53—ulcerative colitis	1.23e-05	0.000785	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ABCB1—ulcerative colitis	1.2e-05	0.000771	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ADCY5—ulcerative colitis	1.2e-05	0.000769	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL20—ulcerative colitis	1.2e-05	0.000768	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—GHRL—ulcerative colitis	1.16e-05	0.00074	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PTGER4—ulcerative colitis	1.15e-05	0.000734	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADRB2—ulcerative colitis	1.13e-05	0.000727	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—GHRL—ulcerative colitis	1.13e-05	0.000724	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GNA12—ulcerative colitis	1.13e-05	0.000722	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ADCY5—ulcerative colitis	1.12e-05	0.000719	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—IL6—ulcerative colitis	1.12e-05	0.000719	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PTGER4—ulcerative colitis	1.12e-05	0.000718	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.11e-05	0.000714	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.07e-05	0.000687	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCR2—ulcerative colitis	1.07e-05	0.000684	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCL8—ulcerative colitis	1.07e-05	0.000684	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADCY5—ulcerative colitis	1.06e-05	0.000679	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.05e-05	0.000673	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—GHRL—ulcerative colitis	1.05e-05	0.000672	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCR1—ulcerative colitis	1.05e-05	0.000669	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PPARG—ulcerative colitis	1.04e-05	0.000665	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—GHRL—ulcerative colitis	1.03e-05	0.000657	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCR1—ulcerative colitis	1.02e-05	0.000655	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CALM3—ulcerative colitis	1.02e-05	0.000651	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR6—ulcerative colitis	1e-05	0.000643	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CALM3—ulcerative colitis	9.94e-06	0.000637	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—JAK2—ulcerative colitis	9.72e-06	0.000622	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADCY5—ulcerative colitis	9.63e-06	0.000617	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DLD—ulcerative colitis	9.62e-06	0.000616	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADRB2—ulcerative colitis	9.56e-06	0.000612	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAML2—ulcerative colitis	9.53e-06	0.00061	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RELA—ulcerative colitis	9.41e-06	0.000602	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—ulcerative colitis	9.39e-06	0.000601	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	9.36e-06	0.000599	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ALB—ulcerative colitis	9.35e-06	0.000598	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—ulcerative colitis	9.19e-06	0.000588	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL20—ulcerative colitis	9.18e-06	0.000587	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL20—ulcerative colitis	8.98e-06	0.000575	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PPARG—ulcerative colitis	8.96e-06	0.000573	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL8—ulcerative colitis	8.87e-06	0.000568	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTGER4—ulcerative colitis	8.85e-06	0.000566	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADRB2—ulcerative colitis	8.68e-06	0.000556	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GNA12—ulcerative colitis	8.63e-06	0.000552	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—ulcerative colitis	8.59e-06	0.00055	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADRB2—ulcerative colitis	8.5e-06	0.000544	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2—ulcerative colitis	8.47e-06	0.000543	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GNA12—ulcerative colitis	8.44e-06	0.000541	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—ulcerative colitis	8.43e-06	0.00054	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—ulcerative colitis	8.41e-06	0.000538	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PPARG—ulcerative colitis	8.38e-06	0.000536	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCR2—ulcerative colitis	8.18e-06	0.000524	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—ulcerative colitis	8.18e-06	0.000523	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL8—ulcerative colitis	8.17e-06	0.000523	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADCY5—ulcerative colitis	8.12e-06	0.00052	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GHRL—ulcerative colitis	8.1e-06	0.000519	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALB—ulcerative colitis	8.05e-06	0.000516	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MMP9—ulcerative colitis	8.02e-06	0.000513	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCR2—ulcerative colitis	8e-06	0.000512	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL8—ulcerative colitis	8e-06	0.000512	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	7.97e-06	0.00051	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	7.94e-06	0.000509	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NFKB1—ulcerative colitis	7.93e-06	0.000508	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CALM3—ulcerative colitis	7.84e-06	0.000502	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RIPK2—ulcerative colitis	7.73e-06	0.000495	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR6—ulcerative colitis	7.69e-06	0.000492	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALB—ulcerative colitis	7.53e-06	0.000482	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR6—ulcerative colitis	7.52e-06	0.000482	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADCY5—ulcerative colitis	7.37e-06	0.000472	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAML2—ulcerative colitis	7.29e-06	0.000467	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADCY5—ulcerative colitis	7.21e-06	0.000462	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAML2—ulcerative colitis	7.13e-06	0.000457	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—STAT3—ulcerative colitis	7.13e-06	0.000457	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—ulcerative colitis	7.05e-06	0.000451	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTGER4—ulcerative colitis	6.77e-06	0.000433	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADRB2—ulcerative colitis	6.7e-06	0.000429	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTGER4—ulcerative colitis	6.62e-06	0.000424	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—JAK2—ulcerative colitis	6.61e-06	0.000423	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TGFB1—ulcerative colitis	6.61e-06	0.000423	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—ulcerative colitis	6.59e-06	0.000422	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GHRL—ulcerative colitis	6.2e-06	0.000397	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GHRL—ulcerative colitis	6.07e-06	0.000388	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL8—ulcerative colitis	6.04e-06	0.000386	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—JAK2—ulcerative colitis	6.01e-06	0.000385	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CALM3—ulcerative colitis	6e-06	0.000384	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RIPK2—ulcerative colitis	5.91e-06	0.000379	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CALM3—ulcerative colitis	5.87e-06	0.000376	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RIPK2—ulcerative colitis	5.79e-06	0.00037	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2—ulcerative colitis	5.77e-06	0.000369	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADCY5—ulcerative colitis	5.69e-06	0.000364	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL8—ulcerative colitis	5.48e-06	0.000351	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—ulcerative colitis	5.44e-06	0.000348	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2—ulcerative colitis	5.24e-06	0.000335	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRB2—ulcerative colitis	5.13e-06	0.000328	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—JAK2—ulcerative colitis	5.06e-06	0.000324	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRB2—ulcerative colitis	5.02e-06	0.000321	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—ulcerative colitis	4.98e-06	0.000319	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—JAK2—ulcerative colitis	4.95e-06	0.000317	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.65e-06	0.000298	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL8—ulcerative colitis	4.62e-06	0.000296	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—JAK2—ulcerative colitis	4.6e-06	0.000294	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	4.52e-06	0.000289	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—JAK2—ulcerative colitis	4.5e-06	0.000288	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2—ulcerative colitis	4.41e-06	0.000283	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADCY5—ulcerative colitis	4.35e-06	0.000279	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2—ulcerative colitis	4.32e-06	0.000277	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADCY5—ulcerative colitis	4.26e-06	0.000273	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL8—ulcerative colitis	4.19e-06	0.000269	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CALM3—ulcerative colitis	4.19e-06	0.000268	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL8—ulcerative colitis	4.1e-06	0.000263	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2—ulcerative colitis	4.01e-06	0.000257	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2—ulcerative colitis	3.92e-06	0.000251	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JAK2—ulcerative colitis	3.55e-06	0.000227	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RELA—ulcerative colitis	3.44e-06	0.00022	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.26e-06	0.000208	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL8—ulcerative colitis	3.24e-06	0.000207	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2—ulcerative colitis	3.09e-06	0.000198	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—ulcerative colitis	3.08e-06	0.000197	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.04e-06	0.000194	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—ulcerative colitis	2.93e-06	0.000188	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NFKB1—ulcerative colitis	2.9e-06	0.000186	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JAK2—ulcerative colitis	2.71e-06	0.000174	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JAK2—ulcerative colitis	2.66e-06	0.00017	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RELA—ulcerative colitis	2.63e-06	0.000168	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STAT3—ulcerative colitis	2.6e-06	0.000167	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RELA—ulcerative colitis	2.57e-06	0.000165	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	2.48e-06	0.000159	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL8—ulcerative colitis	2.42e-06	0.000155	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—ulcerative colitis	2.41e-06	0.000155	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2—ulcerative colitis	2.37e-06	0.000152	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—ulcerative colitis	2.36e-06	0.000151	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2—ulcerative colitis	2.32e-06	0.000148	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—ulcerative colitis	2.31e-06	0.000148	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.27e-06	0.000145	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—ulcerative colitis	2.24e-06	0.000143	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	2.22e-06	0.000142	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—ulcerative colitis	2.19e-06	0.00014	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NFKB1—ulcerative colitis	2.17e-06	0.000139	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—ulcerative colitis	2.04e-06	0.00013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT3—ulcerative colitis	1.99e-06	0.000128	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—ulcerative colitis	1.99e-06	0.000127	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT3—ulcerative colitis	1.95e-06	0.000125	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	1.85e-06	0.000118	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—ulcerative colitis	1.82e-06	0.000116	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—ulcerative colitis	1.81e-06	0.000116	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.78e-06	0.000114	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—ulcerative colitis	1.52e-06	9.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—ulcerative colitis	1.49e-06	9.53e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—ulcerative colitis	1.39e-06	8.91e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—ulcerative colitis	1.36e-06	8.72e-05	CbGpPWpGaD
